Evaluation of High-Performance Curcumin Nanocrystals for Pulmonary Drug Delivery Both In Vitro and In Vivo

Nanoscale Research Letters

Volumn 10, Issue 1, 2015, Pages

  Hu, Liandong ^a   Kong, Dongqian ^a   Hu, Qiaofeng ^b   Gao, Na ^a   Pang, Saixi ^a  

^a HEBEI UNIVERSITY   (China)

^b Shijiazhuang Pharmaceutical Group Co Ltd (CSPC)   (China)

Author keywords

Curcumin; Nanocrystals; Pulmonary delivery; Tissue distribution; Wet milling

Indexed keywords

AERODYNAMICS; BIOLOGICAL ORGANS; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MILLING (MACHINING); NANOCRYSTALLINE POWDERS; NANOCRYSTALS; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TISSUE; X RAY DIFFRACTION;

AERO-DYNAMIC PERFORMANCE; CURCUMIN; POWDER X-RAY DIFFRACTION (PXRD); PULMONARY ADMINISTRATIONS; PULMONARY DELIVERY; PULMONARY DRUG DELIVERY; TISSUE DISTRIBUTIONS; WET MILLING;

ELECTRIC IMPEDANCE;

EID: 84942872422     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/s11671-015-1085-y     Document Type: Article

References (13)

1. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors. 2013;39:2–13.
2. Kumaravel M, Sankar P, Latha P, Benson CS, Rukkumani R. Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin. Nat Prod Commun. 2013;8:183–6.
3. Avasarala S, Zhang F, Liu G, Wang R, London SD, London L, et al. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. Plos One. 2013;8:e57285.
4. Peng F, Tao Q, Wu X, Dou H, Spencer S, Mang C, et al. Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia. 2012;83:568–85.
5. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11:464–73.
6. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–18.
7. Wei X-L, Han Y-R, Quan L-H, Liu C-Y, Liao Y-H. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation. Eur J Pharm Sci. 2013;49:286–93.
8. Jain RA, Brito L, Straub JA, Tessier T, Bernstein H. Effect of powder processing on performance of fenofibrate formulations. Eur J Pharm Biopharm. 2008;69:727–34.
9. Liu P, Rong X, Laru J, Veen B van, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215–22.
10. Courrier H, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst. 2002;19:425–98.
11. Xu L-M, Hu T-T, Pu Y, Le Y, Chen J-F, Wang J-X, et al. Preparation of high-performance ultrafine budesonide particles for pulmonary drug delivery. Chem Eng J. 2014;252:281–7.
12. Rohani SSR, Abnous K, Tafaghodi M. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients. Int J Pharm. 2014;465:464–78.
13. Klingler C, Müller BW, Steckel H. Insulin-micro-and nanoparticles for pulmonary delivery. Int J Pharm. 2009;377:173–9.